On the anticancer clinical activity of perillyl alcohol and limonene: A critical assessment of the outcomes
<p>Monoterpenes with p-menthane structure (perillyl series) can inhibit Ras-proteins prenylation involved in carcinogenesis processes. To evaluate the safety and efficacy of perillyl alcohol (POH) and limonene to treat any type of human cancer, we conducted a systematic review of clinical stud...
Saved in:
Main Authors: | Paula G Santos (Author), Francisco JR Paumgartten (Author), Antonio C Siani (Author) |
---|---|
Format: | Book |
Published: |
Open Journal of Pharmacology and Pharmacotherapeutics - Peertechz Publications,
2022-08-23.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers
by: Thomas C. Chen, et al.
Published: (2021) -
Optimal Design of THEDES Based on Perillyl Alcohol and Ibuprofen
by: Eduardo Silva, et al.
Published: (2020) -
Perillyl alcohol as a treatment for cancer: A systematic review
by: Aimée Obolari Durço, et al.
Published: (2021) -
Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
by: Samila Horst Peczek, et al.
Published: (2023) -
Perillyl alcohol has antibacterial effects and reduces ROS production in macrophages
by: Rebeca Dantas Alves FIGUEIREDO, et al.